Literature DB >> 3003914

Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species.

T St John, W M Gallatin, M Siegelman, H T Smith, V A Fried, I L Weissman.   

Abstract

The lymphocyte cell surface receptor for the high endothelial venules (HEV's) of peripheral lymph nodes is specifically recognized by the monoclonal antibody MEL-14. Three independent complementary DNA (cDNA) clones, each of which encodes the protein ubiquitin, were detected by virtue of the expression of the MEL-14 antigenic determinant on cDNA-beta-galactosidase bacterial fusion proteins. The antigenic determinant defined by MEL-14 resides in the carboxyl terminal 13-amino-acid proteolytic peptide of ubiquitin, but is undetected in intact undenatured ubiquitin and other cellular ubiquitinated proteins. Antisera and monoclonal antibodies to ubiquitin determinants bind to the surface of both HEV-receptor positive and negative cell lines. The MEL-14-identified cDNA clones hydridize to RNA transcripts that encode tandemly repeated ubiquitins. Sequence analysis of these polyubiquitin cDNA's does not identify a leader sequence for export to the cell surface. The expression of the MEL-14 epitope of ubiquitin depends upon its local environment. The steady-state levels of expression of the ubiquitin messenger RNA's do not correlate with either the tissue derivation of the RNA or the expression of the lymphocyte HEV receptor. Regulation of the expression of the HEV receptor is not likely to reflect the transcriptional control of ubiquitin genes, but rather to reflect control of the expression of the HEV core polypeptide or its level or form of ubiquitination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003914     DOI: 10.1126/science.3003914

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  39 in total

Review 1.  Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.

Authors:  Robert Sackstein
Journal:  Ann Biomed Eng       Date:  2011-11-09       Impact factor: 3.934

2.  Essential factors determining codon usage in ubiquitin genes.

Authors:  K Mita; S Ichimura; M Nenoi
Journal:  J Mol Evol       Date:  1991-09       Impact factor: 2.395

3.  Ubiquitin is a component of polypeptides purified from corpora amylacea of aged human brain.

Authors:  S Cissé; G Lacoste-Royal; J Laperrière; T Cabana; D Gauvreau
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

4.  Sequence analysis and transcriptional regulation by heat shock of polyubiquitin transcripts from maize.

Authors:  A H Christensen; P H Quail
Journal:  Plant Mol Biol       Date:  1989-06       Impact factor: 4.076

5.  Ubiquitin-EP52 fusion protein homologs from Trypanosoma brucei.

Authors:  S Wong; T H Morales; D A Campbell
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

6.  cDNA encoding a human homolog of yeast ubiquitin 1.

Authors:  G Salvesen; C Lloyd; D Farley
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

7.  Structure of two developmentally regulated Dictyostelium discoideum ubiquitin genes.

Authors:  R Giorda; H L Ennis
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

8.  Ubiquitin has intrinsic proteolytic activity: implications for cellular regulation.

Authors:  V A Fried; H T Smith; E Hildebrandt; K Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains.

Authors:  S Cissé; G Perry; G Lacoste-Royal; T Cabana; D Gauvreau
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Human homologue of mouse lymph node homing receptor: evolutionary conservation at tandem cell interaction domains.

Authors:  M H Siegelman; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.